In this report, we have shown that NKG2D ligand RAE1ε expressed on tumour cells facilitates expansion and activation of immunosuppressive MDSCs in vitro and in vivo, thereby providing a novel mechanism by which NKG2D ligands inhibit immunosurveillance and lead to tumour progression. The gene discussed is KLRK1; the disease is neoplasm.